TESTBANK
,Table of Contents
n n
Chapter 01: The Nursing Process and Drug Therapy ........................................................................................ 4
n n n n n n n
Chapter 02: Pharmacologic Principles ............................................................................................................. 8
n n n
Chapter 03: Lifespan Considerations ............................................................................................................ 14
n n n
Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................. 20
n n n n n n
Chapter 05: Medication Errors: Preventing and Responding ......................................................................... 26
n n n n n n
Chapter 06: Patient Education and Drug Therapy .......................................................................................... 29
n n n n n n
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .................................................. 34
n n n n n n n n
Chapter 08: Gene Therapy and Pharmacogenomics ...................................................................................... 38
n n n n n
Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 41
n n n n n n
Chapter 10: Analgesic Drugs ......................................................................................................................... 50
n n n
Chapter 11: General and Local Anesthetics ................................................................................................... 57
n n n n n
Chapter 12: Central Nervous System Depressants andMuscle Relaxants ...................................................... 61
n n n n n n n n
Chapter 13: Central Nervous System Stimulants and Related Drugs .............................................................. 66
n n n n n n n n
Chapter 14: Antiepileptic Drugs .................................................................................................................... 70
n n n
Chapter 15: Antiparkinson Drugs .................................................................................................................. 76
n n n
Chapter 16: Psychotherapeutic Drugs .......................................................................................................... 81
n n n
Chapter 17: Substance Use Disorder ............................................................................................................. 88
n n n n
Chapter 18: Adrenergic Drugs ....................................................................................................................... 93
n n n
Chapter 19: Adrenergic-Blocking Drugs ........................................................................................................ 98
n n n
Chapter 20: Cholinergic Drugs .................................................................................................................... 103
n n n
Chapter 21: Cholinergic-Blocking Drugs...................................................................................................... 108
n n n
Chapter22: Antihypertensive Drugs ........................................................................................................... 113
n n n
Chapter 23: Antianginal Drugs .................................................................................................................... 119
n n n
Chapter 24: Heart Failure Drugs .................................................................................................................. 125
n n n n
Chapter 25: Antidysrhythmic Drugs ............................................................................................................ 131
n n n
Chapter 26: Coagulation Modifier Drugs ..................................................................................................... 137
n n n n
Chapter 27: Antilipemic Drugs .................................................................................................................... 143
n n n
Chapter 28: Diuretic Drugs .......................................................................................................................... 148
n n n
Chapter 29: Fluids and Electrolytes ............................................................................................................. 154
n n n n
Chapter 30: Pituitary Drugs ......................................................................................................................... 160
n n n
,Chapter 31: Thyroid and Antithyroid Drugs ................................................................................................. 163
n n n n n
Chapter 32: Antidiabetic Drugs ................................................................................................................... 168
n n n
Chapter 33: Adrenal Drugs .......................................................................................................................... 177
n n n
Chapter 34: Women’s Health Drugs ............................................................................................................ 181
n n n n
Chapter 35: Men’s Health Drugs ................................................................................................................. 188
n n n n
Chapter36: Antihistamines, Decongestants, Antitussives, and Expectorants.............................................. 193
n n n n n n
Chapter 37: Respiratory Drugs .................................................................................................................... 198
n n n
Chapter 38: Antibiotics Part 1...................................................................................................................... 204
n n n n
Chapter 39: Antibiotics Part 2...................................................................................................................... 211
n n n n
Chapter 40: Antiviral Drugs ......................................................................................................................... 216
n n n
Chapter 41: Antitubercular Drugs ............................................................................................................... 221
n n n
Chapter 42: Antifungal Drugs ...................................................................................................................... 226
n n n
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................... 231
n n n n n n
Chapter 44: Anti-inflammatory and Antigout Drugs .................................................................................... 236
n n n n n
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs............................. 242
n n n n n n n n n n n
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ................ 248
n n n n n n n n n n n
Chapter47: Biologic Response–Modifyingand Antirheumatic Drugs .......................................................... 253
n n n n n n
Chapter 48: Immunosuppressant Drugs ..................................................................................................... 258
n n n
Chapter 49: Immunizing Drugs.................................................................................................................... 263
n n n
Chapter 50: Acid-Controlling Drugs ............................................................................................................ 268
n n n
Chapter 51: Bowel Disorder Drugs .............................................................................................................. 274
n n n n
Chapter 52: Antiemetic and Antinausea Drugs............................................................................................ 281
n n n n n
Chapter 53: Vitamins and Minerals ............................................................................................................. 286
n n n n
Chapter 54: Anemia Drugs .......................................................................................................................... 292
n n n
Chapter 55: Nutritional Supplements ......................................................................................................... 299
n n n
Chapter 56: Dermatologic Drugs ................................................................................................................. 304
n n n
Chapter 57: Ophthalmic Drugs .................................................................................................................... 310
n n n
Chapter 58: Otic Drugs ................................................................................................................................ 315
n n n
, Chapter 01: The Nursing Process and Drug Therapy n n n n n n n n n n 4
Chapter 01: The Nursing Process andDrug Therapy n n n n n n n
MULTIPLE CHOICE n
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
n n n n n n n n n n n n n n n n n n
ndiagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
n n n n n n n n n n n n n
ndiagnosis?
a. Anxiety
b. Anxietyrelated to new drug therapy n n n n n
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by statements
n n n n n n n n n n n
such as “I’m upset about having to test my blood sugars.”
n n n n n n n n n n n
d. Anxietyrelated to new drug therapy, as evidenced bystatements such as “I’m
n n n n n n n n n n n n
upset about having to test my blood sugars.”
n n n n n n n n
ANS: D n
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
n n n n n n n n n n n n n
to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drugtherapy”
n n n n n n n n n n n n n n n
is missing the “as evidenced by” portion of defining characteristics. The statement beginning
n n n n n n n n n n n n n
“Anxiety related to anxious feelings” is incorrect because the “related to” section is simply a
n n n n n n n n n n n n n n n
restatement of the problem “anxiety,” not a separate factor related to the response.
n n n n n n n n n n n n n
DIF: COGNITIVE LEVEL: Understanding(Comprehension) n n n
TOP: NURSING PROCESS: Nursing Diagnosis
n n n n n
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
n n n n n n n n n
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave
n n n n n n n n n n n n n n n n n
nthe medication 2 hours after the scheduled dose was due. What type of problem does this represent?
n n n n n n n n n n n n n n n n
a. “Right time” n
b. “Right dose” n
c. “Right route” n
d. “Right medication” n
ANS: A n
“Right time” is correct because the medication was given more than 30 minutes after the scheduled
n n n n n n n n n n n n n n n
dose was due. “Dose” is incorrect because the dose is not related to the time the medication
n n n n n n n n n n n n n n n n n
administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
n n n n n n n n n n n n n n
incorrect because the medication ordered will not change.
n n n n n n n n
DIF: COGNITIVE LEVEL: Applying(Application) n n n
TOP: NURSING PROCESS: Implementation
n n n n
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
n n n n n n n n n n
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
n n n n n n n n n n n n n n n n n
documenting the patient’s therapeutic response to the medication. Which phase of the nursing
n n n n n n n n n n n n n
process do these actions illustrate?
n n n n n
a. Nursing diagnosis n
,Table of Contents
n n
Chapter 01: The Nursing Process and Drug Therapy ........................................................................................ 4
n n n n n n n
Chapter 02: Pharmacologic Principles ............................................................................................................. 8
n n n
Chapter 03: Lifespan Considerations ............................................................................................................ 14
n n n
Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................. 20
n n n n n n
Chapter 05: Medication Errors: Preventing and Responding ......................................................................... 26
n n n n n n
Chapter 06: Patient Education and Drug Therapy .......................................................................................... 29
n n n n n n
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .................................................. 34
n n n n n n n n
Chapter 08: Gene Therapy and Pharmacogenomics ...................................................................................... 38
n n n n n
Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 41
n n n n n n
Chapter 10: Analgesic Drugs ......................................................................................................................... 50
n n n
Chapter 11: General and Local Anesthetics ................................................................................................... 57
n n n n n
Chapter 12: Central Nervous System Depressants andMuscle Relaxants ...................................................... 61
n n n n n n n n
Chapter 13: Central Nervous System Stimulants and Related Drugs .............................................................. 66
n n n n n n n n
Chapter 14: Antiepileptic Drugs .................................................................................................................... 70
n n n
Chapter 15: Antiparkinson Drugs .................................................................................................................. 76
n n n
Chapter 16: Psychotherapeutic Drugs .......................................................................................................... 81
n n n
Chapter 17: Substance Use Disorder ............................................................................................................. 88
n n n n
Chapter 18: Adrenergic Drugs ....................................................................................................................... 93
n n n
Chapter 19: Adrenergic-Blocking Drugs ........................................................................................................ 98
n n n
Chapter 20: Cholinergic Drugs .................................................................................................................... 103
n n n
Chapter 21: Cholinergic-Blocking Drugs...................................................................................................... 108
n n n
Chapter22: Antihypertensive Drugs ........................................................................................................... 113
n n n
Chapter 23: Antianginal Drugs .................................................................................................................... 119
n n n
Chapter 24: Heart Failure Drugs .................................................................................................................. 125
n n n n
Chapter 25: Antidysrhythmic Drugs ............................................................................................................ 131
n n n
Chapter 26: Coagulation Modifier Drugs ..................................................................................................... 137
n n n n
Chapter 27: Antilipemic Drugs .................................................................................................................... 143
n n n
Chapter 28: Diuretic Drugs .......................................................................................................................... 148
n n n
Chapter 29: Fluids and Electrolytes ............................................................................................................. 154
n n n n
Chapter 30: Pituitary Drugs ......................................................................................................................... 160
n n n
,Chapter 31: Thyroid and Antithyroid Drugs ................................................................................................. 163
n n n n n
Chapter 32: Antidiabetic Drugs ................................................................................................................... 168
n n n
Chapter 33: Adrenal Drugs .......................................................................................................................... 177
n n n
Chapter 34: Women’s Health Drugs ............................................................................................................ 181
n n n n
Chapter 35: Men’s Health Drugs ................................................................................................................. 188
n n n n
Chapter36: Antihistamines, Decongestants, Antitussives, and Expectorants.............................................. 193
n n n n n n
Chapter 37: Respiratory Drugs .................................................................................................................... 198
n n n
Chapter 38: Antibiotics Part 1...................................................................................................................... 204
n n n n
Chapter 39: Antibiotics Part 2...................................................................................................................... 211
n n n n
Chapter 40: Antiviral Drugs ......................................................................................................................... 216
n n n
Chapter 41: Antitubercular Drugs ............................................................................................................... 221
n n n
Chapter 42: Antifungal Drugs ...................................................................................................................... 226
n n n
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................... 231
n n n n n n
Chapter 44: Anti-inflammatory and Antigout Drugs .................................................................................... 236
n n n n n
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs............................. 242
n n n n n n n n n n n
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ................ 248
n n n n n n n n n n n
Chapter47: Biologic Response–Modifyingand Antirheumatic Drugs .......................................................... 253
n n n n n n
Chapter 48: Immunosuppressant Drugs ..................................................................................................... 258
n n n
Chapter 49: Immunizing Drugs.................................................................................................................... 263
n n n
Chapter 50: Acid-Controlling Drugs ............................................................................................................ 268
n n n
Chapter 51: Bowel Disorder Drugs .............................................................................................................. 274
n n n n
Chapter 52: Antiemetic and Antinausea Drugs............................................................................................ 281
n n n n n
Chapter 53: Vitamins and Minerals ............................................................................................................. 286
n n n n
Chapter 54: Anemia Drugs .......................................................................................................................... 292
n n n
Chapter 55: Nutritional Supplements ......................................................................................................... 299
n n n
Chapter 56: Dermatologic Drugs ................................................................................................................. 304
n n n
Chapter 57: Ophthalmic Drugs .................................................................................................................... 310
n n n
Chapter 58: Otic Drugs ................................................................................................................................ 315
n n n
, Chapter 01: The Nursing Process and Drug Therapy n n n n n n n n n n 4
Chapter 01: The Nursing Process andDrug Therapy n n n n n n n
MULTIPLE CHOICE n
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
n n n n n n n n n n n n n n n n n n
ndiagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
n n n n n n n n n n n n n
ndiagnosis?
a. Anxiety
b. Anxietyrelated to new drug therapy n n n n n
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by statements
n n n n n n n n n n n
such as “I’m upset about having to test my blood sugars.”
n n n n n n n n n n n
d. Anxietyrelated to new drug therapy, as evidenced bystatements such as “I’m
n n n n n n n n n n n n
upset about having to test my blood sugars.”
n n n n n n n n
ANS: D n
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
n n n n n n n n n n n n n
to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drugtherapy”
n n n n n n n n n n n n n n n
is missing the “as evidenced by” portion of defining characteristics. The statement beginning
n n n n n n n n n n n n n
“Anxiety related to anxious feelings” is incorrect because the “related to” section is simply a
n n n n n n n n n n n n n n n
restatement of the problem “anxiety,” not a separate factor related to the response.
n n n n n n n n n n n n n
DIF: COGNITIVE LEVEL: Understanding(Comprehension) n n n
TOP: NURSING PROCESS: Nursing Diagnosis
n n n n n
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
n n n n n n n n n
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave
n n n n n n n n n n n n n n n n n
nthe medication 2 hours after the scheduled dose was due. What type of problem does this represent?
n n n n n n n n n n n n n n n n
a. “Right time” n
b. “Right dose” n
c. “Right route” n
d. “Right medication” n
ANS: A n
“Right time” is correct because the medication was given more than 30 minutes after the scheduled
n n n n n n n n n n n n n n n
dose was due. “Dose” is incorrect because the dose is not related to the time the medication
n n n n n n n n n n n n n n n n n
administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
n n n n n n n n n n n n n n
incorrect because the medication ordered will not change.
n n n n n n n n
DIF: COGNITIVE LEVEL: Applying(Application) n n n
TOP: NURSING PROCESS: Implementation
n n n n
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
n n n n n n n n n n
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
n n n n n n n n n n n n n n n n n
documenting the patient’s therapeutic response to the medication. Which phase of the nursing
n n n n n n n n n n n n n
process do these actions illustrate?
n n n n n
a. Nursing diagnosis n
